Latest / Washington DC News Today | 2 Min News | The Daily News Now!
FDA Approves Groundbreaking KRAS Lung Cancer Drug | Washington DC News
FDA just approved a groundbreaking new drug for a rare form of lung cancer — the first effective treatment for tumors with the elusive KRAS G12C mutation, once deemed “undruggable.” Clinical trials showed dramatic tumor shrinkage and slowed disease progression in hundreds of patients, earning accelerated approval to reach patients faster. This milestone in precision medicine proves that targeting a cancer’s genetic roots can deliver powerful, personalized results — and it’s just the beginning of a new era in cancer treatment. Thank you to our sponsor Garrett Waller Performance…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.